Event coordinated by the Hepatitis B Foundation

International HBV Meeting Program

Please join us for this hybrid meeting, September 18 -22. If you will be attending in-person, we'll see you at the Novotel Paris Centre Tour Eiffel. Online attendance is also available. 
*Program is subject to change. All times are Paris Local Time (Central European Summer Time through October).  
 
HBV Mtg Program Button

Sunday, September 18, 2022

 15:00 - 15:10 Welcome address by co-organizers
 15:10 – 15:50

Distinguished Award in HBV research Lecture 
Professor Fabien Zoulim (Lyon University, Hospices Civils de Lyon, Inserm, CRCL) 

 15:50 – 16:50 Top of the art lecture by Pr Ralf Bartenschlager (Albert-Lasker award winner; University of Heidelberg - DZIF, Germany) (45min and Q&A 15min)
 16:50 - 17:00 Welcome address by Pr Yazdan Yadanpanah (Director of ANRS-MIE, France)
 17:00 – 19:00

SESSION I: Novel technologies and model systems
Chairs: Maura Dandri (Germany) & Robert Schwartz (USA) 

 19:00 - 21:00 Welcome reception on site
Monday, September 19, 2022
 08:30 - 10:30  SESSION II: Viral entry and Episome biogenesis 
Chairs: Koichi Watashi (Japan) & Barbara Testoni (France)
 10:30 - 11:00  Coffee break
 11:00 – 13:00 SESSION III: From the viral genome to viral particle egress. 
Chairs: Patrick Soussan (France) & Aleem Siddiqui (USA)
 13:00 – 14:00 Lunch
 14:00 - 16:00 SESSION IV: Virus-host cross-talks/interactions
Chairs: Jane Mc Keating (UK) & Yuchen Xia (China)
 16:00 - 16:30 Coffee break
 16:30 - 17:30

Keynote lecture - Professor Mathias Heikenwälder(University of Heidelberg - DKFZ, Germany)

 17:30 - 20:00  

Poster session I  

Tuesday, September 20, 2022  
 08:00 - 10:00 SESSION V: Innate immune responses
Chairs: Sonja Buschow (The Netherlands) & Luca Guidotti (Italy) 
 10:00 - 10:30 Coffee break
 10:30 - 12:30  SESSION VI: Adaptive immune responses. 
Chairs: Mala Maini (UK) & Nina Le Bert (Singapore) 
 12:30 - 13:30 Lunch
 13:30 - 16:00 Poster session II  
 16:00 - 16:30 Coffee break
 16:30 - 18:30 SESSION VII: Viral pathogenesis, integration and hepatocellular carcinoma. 
Chairs: Massimo Levrero (France) & Michael Bouchard (USA) 
 18:30 - 18:45  Hepatitis B Foundation update – Dr. Chari Cohen, President
 18:45 - 19:00  Updates - ICE-HBV
Wednesday, September 21, 2022  
 08:30 - 10:30  SESSION VIII: Preclinical targets & therapies for CHB and CHD. 
Chairs: Ulrike Protzer (Germany) & Jake Liang (USA) 
 10:30 - 11:00 Coffee break
 11:00 - 12:00 Keynote lecture - by Professor Michaela Müller-Trutwin (Institut Pasteur, France)
 12:00 - 13:30 Lunch and “HBF Young fellow” networking meeting 
 13:30 - 15:30 SESSION IX: Genotypes, co-evolution, co-infections 
Chairs: Anna Kramvis (South Africa) & Peter Revill (Australia) 
 15:30 - 16:00 Coffee break
 16:00 - 18:30 Symposium on “Drug Discovery”. 
Chairs: Raymond Schinazi (USA) & Fabien Zoulim (France)
 18:30 - 19:00 Farewell & next meeting presentation
 From 20h Gala dinner 
Thursday, September 22, 2022  
 07:30 - 09:30  HBF and ICE-HBV Community Forum (with ANRS participation)
 9:30 – 10:00  Coffee break
 10:00 - 13:00  ICE-HBV Symposium